Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeaki Ohno

Showing results (1-10 of 255) with videos related to

Pageof 26
Sort By:
Nippon Ganka Gakkai Zasshi|January 18, 2006
[Studies on exogenous and endogenous factors associated with various ocular diseases]Shigeaki Ohno
Nippon Ganka Gakkai Zasshi|February 6, 2013
[A multicenter, double-masked, randomized evaluation of olopatadine 0.2% using the conjunctival allergen challenge model in Japanese patients with allergic conjunctivitis]Shigeaki Ohno,
Nippon Ganka Gakkai Zasshi|March 1, 2003
[Guidelines on the viral conjunctivitis]Shigeaki Ohno, Koki Aoki
Arerugi = [Allergy]|August 3, 2006
[Diagnosis and treatment of allergic conjunctival disease]Chiho Goda, Shigeaki Ohno
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2005
[Behçet's disease]Nobuyoshi Kitaichi, Shigeaki Ohno
Ocular Immunology and Inflammation|December 23, 2011
HLA-B*51 and Behçet DiseaseAhmet Gul, Shigeaki Ohno
Nippon Ganka Gakkai Zasshi|October 25, 2012
[A 10-week safety and efficacy evaluation of olopatadine, 0.2% instilled twice-daily in patients with allergic conjunctivitis in Japan]Shigeaki Ohno, Makoto Ando
International Ophthalmology Clinics|March 26, 2005
Anti-tumor necrosis factor alpha antibody in the treatment of Behçet's diseaseSatoshi Nakamura, Shigeaki Ohno
International Ophthalmology Clinics|August 23, 2002
Helper T-cell subsets in uveitisYumi Imai, Shigeaki Ohno
Arerugi = [Allergy]|August 21, 2003
[Eye involvement of autoimmune disease]Yumiko Shindo, Shigeaki Ohno
Pageof 26

Showing results (1-10 of 255) with videos related to

Sort By:
Pageof 26
Nippon Ganka Gakkai Zasshi|January 18, 2006
[Studies on exogenous and endogenous factors associated with various ocular diseases]Shigeaki Ohno
Nippon Ganka Gakkai Zasshi|February 6, 2013
[A multicenter, double-masked, randomized evaluation of olopatadine 0.2% using the conjunctival allergen challenge model in Japanese patients with allergic conjunctivitis]Shigeaki Ohno,
Nippon Ganka Gakkai Zasshi|March 1, 2003
[Guidelines on the viral conjunctivitis]Shigeaki Ohno, Koki Aoki
Arerugi = [Allergy]|August 3, 2006
[Diagnosis and treatment of allergic conjunctival disease]Chiho Goda, Shigeaki Ohno
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2005
[Behçet's disease]Nobuyoshi Kitaichi, Shigeaki Ohno
Ocular Immunology and Inflammation|December 23, 2011
HLA-B*51 and Behçet DiseaseAhmet Gul, Shigeaki Ohno
Nippon Ganka Gakkai Zasshi|October 25, 2012
[A 10-week safety and efficacy evaluation of olopatadine, 0.2% instilled twice-daily in patients with allergic conjunctivitis in Japan]Shigeaki Ohno, Makoto Ando
International Ophthalmology Clinics|March 26, 2005
Anti-tumor necrosis factor alpha antibody in the treatment of Behçet's diseaseSatoshi Nakamura, Shigeaki Ohno
International Ophthalmology Clinics|August 23, 2002
Helper T-cell subsets in uveitisYumi Imai, Shigeaki Ohno
Arerugi = [Allergy]|August 21, 2003
[Eye involvement of autoimmune disease]Yumiko Shindo, Shigeaki Ohno
Pageof 26